SALT LAKE CITY, April 20, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced ...

Quest Diagnostics DGX is set to release its second-quarter 2025 results on July 22, before the market opens. The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.21 in the ...

Diversified science and technology company Danaher (NYSE:DHR) in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion.

Michael Cherny, an analyst from Leerink Partners, maintained the Hold rating on Quest Diagnostics (DGX – Research Report). The associated price target is $169.00. Don't Miss our Black Friday Offers: ...

SAN FRANCISCO--(BUSINESS WIRE)--Fiddler, the pioneer in Model Performance Management (MPM), today launched a powerful set of capabilities in analytics, diagnostics, and vector monitoring to help ...

On Tuesday, Quest Diagnostics Inc (NYSE:DGX) posted second-quarter adjusted EPS of $2.35, beating the consensus of $2.34. Sales increased 2.5% year-over-year to $2.39 billion, almost in line with the ...

Assessing the skills of junior female footballers in realistic game situations: this is now possible with the new SCoRE performance diagnostics system developed by the University of Würzburg. The ...